4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Modern Chinese Medicine Group Co., Ltd. (1643) operates in the Drug Manufacturers - General industry and is headquartered in Chengde, China with about 189 employees. Its market capitalization is roughly HK$479 million. In the fiscal year ended 2025-12-31, 1643 reported CNY 145M in revenue and (CNY 14M) in net income.
Modern Chinese Medicine Group Co., Ltd., an investment holding company, engages in the production and sale of proprietary Chinese medicines in the People's Republic of China.
Interactive charts & full statements → Open the 1643 valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 145M | CNY 214M | CNY 344M | CNY 400M | — |
| Gross Profit | CNY 24M | CNY 55M | CNY 104M | CNY 171M | — |
| Operating Income (EBIT) | (CNY 16M) | CNY 24M | CNY 68M | CNY 129M | — |
| Net Income | (CNY 14M) | CNY 10M | CNY 49M | CNY 88M | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | — | — | — | (CNY 8M) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 543M | CNY 540M | CNY 528M | CNY 502M | — |
| Total Liabilities | CNY 45M | CNY 56M | CNY 56M | CNY 79M | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 1643 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms